Discovery of a highly selective caspase-3 substrate for imaging live cells

ACS Chemical Biology

Volumn 9, Issue 10, 2014, Pages 2199-2203

  Vickers, Chris J ^a   González Páez, Gonzalo E ^a   Wolan, Dennis W ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CASPASE 6; CASPASE 7; CASPASE 8; CASPASE 9; CELL PENETRATING PEPTIDE;

APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CELL IMAGING; CELL LYSATE; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; ENZYME ACTIVITY; FLUORESCENCE IMAGING; IN VITRO STUDY; PEPTIDE SYNTHESIS; PROCEDURES CONCERNING CELLS; ENZYME SPECIFICITY; FLUORESCENCE RESONANCE ENERGY TRANSFER; HELA CELL LINE; HUMAN; MCF 7 CELL LINE; METABOLISM; MOLECULAR IMAGING; PROCEDURES;

APOPTOSIS; CASPASE 3; FLUORESCENCE RESONANCE ENERGY TRANSFER; HELA CELLS; HUMANS; MCF-7 CELLS; MOLECULAR IMAGING; SUBSTRATE SPECIFICITY;

EID: 84908156319     PISSN: 15548929     EISSN: 15548937     Source Type: Journal    
DOI: 10.1021/cb500586p     Document Type: Article

References (35)

1. Riedl, J. R., and Shi, Y. (2004) Molecular mechanisms of caspase regulation during apoptosis. Nat. Rev. Mol. Cell Biol. 5, 897-907.
2. Martin, S. J., Henry, C. M., and Cullen, S. P. (2012) A perspective on mammalian caspases as positive and negative regulators of inflammation. Mol. Cell 46, 387-397.
3. Fernando, P., Kelly, J. F., Balazsi, K., Slack, R. S., and Megeney, L. A. (2002) Caspase-3 activity is required for skeletal muscle differentiation. Proc. Natl. Acad. Sci. U.S.A. 99, 11025-11030.
4. Fujita, J., Crane, A. M., Souza, M. K., Dejosez, M., Kyba, M., Flavell, R. A., Thomson, J. A., and Zwaka, T. P. (2008) Caspase activity mediates the differentiation of embryonic stem cells. Cell Stem Cell 2, 595-601.
5. Basu, S., Rajakaruna, S., and Menko, A. S. (2012) Insulin-like growth factor receptor-1 and nuclear factor κB are crucial survival signals that regulate caspase-3-mediated lens epithelial cell differentiation initiation. J. Biol. Chem. 287, 8384-8397.
6. Su, H., Bidére, N., Zheng, L., Cubre, A., Sakai, K., Dale, J., Salmena, L., Hakem, R., Straus, S., and Lenardo, M. (2005) Requirement for caspase-8 in NF-kappaB activation by antigen receptor. Science 307, 1465-1468.
7. Williams, D. W., Kondo, S., Krzyzanowska, A., Hiromi, Y., and Truman, J. W. (2006) Local caspase activity directs engulfment of dendrites during pruning. Nat. Neurosci. 9, 1234-1236.
8. Olson, N. E., Graves, J. D., Shu, G. L., Ryan, E. J., and Clark, E. A. (2003) Caspase activity is required for stimulated B lymphocytes to enter the cell cycle. J. Immunol. 170, 6065-6072.
9. D'Amelio, M., Sheng, M., and Cecconi, F. (2012) Caspase-3 in the central nervous system: beyond apoptosis. Trends Neurosci. 35, 700-709.
10. Graham, R. K., Deng, Y., Slow, E. J., Haigh, B., Bissada, N., Lu, G., Pearson, J., Shehadeh, J., Bertram, L., Murphy, Z., Warby, S. C., Doty, C. N., Roy, S., Wellington, C. L., Leavitt, B. R., Raymond, L. A., Nicholson, D. W., and Hayden, M. R. (2006) Cleavage at the caspase-6 site is required for neuronal dysfunction and degeneration due to mutant huntingtin. Cell 125, 1179-1191.
11. Leyva, M. J., Degiacomo, F., Kaltenbach, L. S., Holcomb, J., Zhang, N., Gafni, J., Park, H., Lo, D. C., Salvesen, G. S., Ellerby, L. M., and Ellman, J. A. (2010) Identification and evaluation of small molecule pan-caspase inhibitors in Huntington's disease models. Chem. Biol. 17, 1189-1200.
12. Putt, K. S., Chen, G. W., Pearson, J. M., Sandhorst, J. S., Hoagland, M. S., Kwon, J.-T., Jin, H., Churchwell, M. I., Cho, M.-H., Doerge, D. R., Helferich, W. G., and Hergenrother, P. J. (2006) Small-molecule activation of procaspase-3 to caspase-3 as a personalized anticancer strategy. Nat. Chem. Biol. 2, 543-550.
13. Wolan, D. W., Zorn, J. A., Gray, D. C., and Wells, J. A. (2009) Small-molecule activators of a proenzyme. Science 326, 853-858.
14. Vickers, C. J., González-Páez, G. E., Umotoy, J. C., Cayanan-Garrett, C., Brown, S. J., and Wolan, D. W. (2013) Small-molecule procaspase activators identified using fluorescence polarization. ChemBioChem 14, 1419-1422.
15. Communal, C., Sumandea, M., de Tombe, P., Narula, J., Solaro, R. J., and Hajjar, R. J. (2002) Functional consequences of caspase activation in cardiac myocytes. Proc. Natl. Acad. Sci. U.S.A. 99, 6252-6256.
16. Hotchkiss, R. S., and Nicholson, D. W. (2006) Apoptosis and caspases regulate death and inflammation in sepsis. Nat. Rev. Immunol. 6, 813-822.
17. Thornberry, N. A., Rano, T. A., Peterson, E. P., Rasper, D. M., Timkey, T., Garcia-Calvo, M., Houtzager, V. M., Nordstrom, P. A., Roy, S., Vaillancourt, J. P., Chapman, K. T., and Nicholson, D. W. (1997) A combinatorial approach defines specificities of members of the caspase family and granzyme B. J. Biol. Chem. 272, 17907-17911.
18. Berger, A. B., Sexton, K. B., and Bogyo, M. (2006) Commonly used caspase inhibitors designed based on substrate specificity profiles lack selectivity. Cell Res. 16, 961-963.
19. Vickers, C. J., González-Páez, G. E., and Wolan, D. W. (2013) Selective detection of caspase-3 versus caspase-7 using activity-based probes with key unnatural amino acids. ACS Chem. Biol. 8, 1558-1566.
20. Vickers, C. J., González-Páez, G. E., and Wolan, D. W. (2013) Selective detection and inhibition of active caspase-3 in cells with optimized peptides. J. Am. Chem. Soc. 135, 12869-12876.
21. Mahrus, S., Trinidad, J. C., Barkan, D. T., Sali, A., Burlingame, A. L., and Wells, J. A. (2008) Global sequencing of proteolytic cleavage sites in apoptosis by specific labeling of protein N-termini. Cell 134, 866-876.
22. Xiao, J., Broz, P., Puri, A. W., Deu, E., Morell, M., Monack, D. M., and Bogyo, M. (2013) A coupled protein and probe engineering approach for selective inhibition and activity-based probe labeling of the caspases. J. Am. Chem. Soc. 135, 9130-9138.
23. Gray, D. C., Mahrus, S., and Wells, J. A. (2010) Activation of specific apoptotic caspases with an engineered small-molecule-activated protease. Cell 142, 637-646.
24. Degterev, A., Boyce, M., and Yuan, J. (2003) A decade of caspases. Oncogene 22, 8543-8567.
25. Barnett, E. M., Zhang, X., Maxwell, D., Chang, Q., and Piwnica-Worms, D. (2009) Single-cell imaging of retinal ganglion cell apoptosis with a cell-penetrating, activatable peptide probe in an in vivo glaucoma model. Proc. Natl. Acad. Sci. U.S.A. 106, 9391-9396.
26. Edgington, L. E., Berger, A. B., Blum, G., Albrow, V. E., Paulick, M. G., Lineberry, N., and Bogyo, M. (2009) Noninvasive optical imaging of apoptosis by caspase-targeted activity-based probes. Nat. Med. 15, 967-973.
27. Shen, B., Jeon, J., Palner, M., Ye, D., Shuhendler, A., Chin, F. T., and Rao, J. (2013) Positron emission tomography imaging of drug-induced tumor apoptosis with a caspase-triggered nanoaggregation probe. Angew. Chem., Int. Ed. 52, 10511-10514.
28. Maxwell, D., Chang, Q., Zhang, X., Barnett, E. M., and Piwnica-Worms, D. (2009) An improved cell-penetrating, caspase-activatable, near-infrared fluorescent peptide for apoptosis imaging. Bioconjugate Chem. 20, 702-709.
29. Stennicke, H. R., Renatus, M., Meldal, M., and Salvesen, G. S. (2000) Internally quenched fluorescent peptide substrates disclose the subsite preferences of human capsases-1, -3, -6, -7, and -8. Biochem. J. 350, 563-568.
30. Johnson, J. R., Kocher, B., Barnett, E. M., Marasa, J., and Piwnica-Worms, D. (2012) Caspase-activated cell-penetrating peptides reveal temporal coupling between endosomal release and apoptosis in an RGC-5 cell model. Bioconjugate Chem. 23, 1783-1793.
31. Poreba, M., Kasperkiewicz, P., Snipas, S. J., Fasci, D., Salvesen, G. S., and Drag, M. (2014) Unnatural amino acids increase sensitivity and provide for the design of highly selective caspase substrates. Cell Death Differ. 21, 1482-1492.
32. Jänicke, R. U., Sprengart, M. L., Wati, M. R., and Porter, A. G. (1998) Caspase-3 is required for DNA fragmentation and morphological changes associated with apoptosis. J. Biol. Chem. 273, 9357-9360.
33. Blanc, C., Deveraux, Q. L., Krajewski, S., Jänicke, R. U., Porter, A. G., Reed, J. C., Jaggi, R., and Marti, A. (2000) Caspase-3 is essential for procaspase-9 processing and cisplatin-induced apoptosis of MCF-7 breast cancer cells. Cancer Res. 60, 4386-4390.
34. Boxer, M. B., Quinn, A. M., Shen, M., Jadhav, A., Leister, W., Simeonov, A., Auld, D. S., and Thomas, C. J. (2010) A highly potent and selective caspase-1 inhibitor that utilizes a key 3-cyanopropanoic acid moiety. ChemMedChem. 5, 730-738.
35. Han, Y., Giroux, A., Colucci, J., Bayly, C. I., Mckay, D. J., Roy, S., Xanthoudakis, S., Vaillancourt, J., Rasper, D. M., Tam, J., Tawa, P., Nicholson, D. W., and Zamboni, R. J. (2005) Novel pyrazinone monoamides as potent and reversible caspase-3 inhibitors. Bioorg. Med. Chem. Lett. 15, 1173-1180.